Clotrimazole And Betamethasone Dipropionate Cream
Product Images NDC 51672-4048

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clotrimazole And Betamethasone Dipropionate (NDC 51672-4048). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Clobezin 01)

Chemical structure diagram showing the molecular arrangement of the active ingredient in Clobezin, specifically representing clotrimazole. The structure includes a central carbon atom bonded to three phenyl groups and a nitrogen-containing imidazole ring with a chlorine substituent on one phenyl ring.*

FDA Label Image

Chemical Structure (Clobezin 02)

Chemical structure diagram of betamethasone dipropionate, one of the active ingredients in Clobezin. The diagram shows the steroid framework with attached ester and ketone functional groups.*

FDA Label Image

Principal Display Panel (Label)

Clobezin kit packaging label showing it contains Clotrimazole and Betamethasone Dipropionate cream USP 1%/0.05%, 15 g tube, and Zinc Oxide Paste 20.6%, 4 g in 30 packets. Label indicates topical use only and storage instructions. Labeler is Skya Health, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.